STING1 and acute respiratory distress syndrome: We hypothesized that STING agonists administered in the airways for anticancer or anti-COVID treatment might induce an inflammatory response, fueled by STING-mediated cell death [12], and we questioned whether STING agonists induce acute respiratory distress syndrome (ARDS), through programmed cell death PANoptosis, including pyroptosis, apoptosis, necroptosis pathways [13].